當前位置：首頁 SCI期刊 SCIE期刊醫學中科院3區 JCRQ2 期刊介紹(非官網)

Acs Medicinal Chemistry LettersSCIE

國際簡稱：ACS Med. Chem. Lett. 參考譯名：Acs 藥物化學快報

中科院分區
3區
CiteScore分區
Q1
JCR分區
Q2

基本信息：: ISSN：1948-5875; 是否OA：開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：UNITED STATES; 出版商：American Chemical Society; 出版語言：English; 出版周期：Monthly; 出版年份：2010; 研究方向：CHEMISTRY, MEDICINAL

評價信息：: 影響因子：3.5; H-index：52; CiteScore指數：7.3; SJR指數：0.883; SNIP指數：0.816

發文數據：: Gold OA文章占比：16.64%; 研究類文章占比：100.00%; 年發文量：216; 自引率：0.0238...; 開源占比：0.1324; 出版撤稿占比：0; 出版國人文章占比：0.09; OA被引用占比：0.0295...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Acs Medicinal Chemistry Letters期刊介紹

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:

Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)

Biological characterization of new molecular entities in the context of drug discovery

Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.

Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry

Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources

Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response

Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic

Mechanistic drug metabolism and regulation of metabolic enzyme gene expression

Chemistry patents relevant to the medicinal chemistry field.

期刊簡介Acs Medicinal Chemistry Letters期刊介紹

《Acs Medicinal Chemistry Letters》自2010出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：一般,3-8周
醫學
CHEMISTRY, MEDICINAL
SCIE
中科院3區
非預警

Cite Score數據（2024年最新版）Acs Medicinal Chemistry Letters Cite Score數據

CiteScore：7.3
SJR：0.883
SNIP：0.816

學科類別	分區	排名	百分位
大類：Chemistry 小類：Organic Chemistry	Q1	43 / 211	79%
大類：Chemistry 小類：Drug Discovery	Q2	45 / 157	71%
大類：Chemistry 小類：Biochemistry	Q2	134 / 438	69%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Acs Medicinal Chemistry Letters 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	3區	CHEMISTRY, MEDICINAL 藥物化學	3區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Acs Medicinal Chemistry Letters JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：CHEMISTRY, MEDICINAL	SCIE	Q2	32 / 72	56.3%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：CHEMISTRY, MEDICINAL	SCIE	Q2	21 / 72	71.53%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
USA447
Italy142
CHINA MAINLAND115
England77
GERMANY (FED REP GER)63
Japan49
Spain32
India30
Switzerland30
France25

本刊中國學者近年發表論文

1、Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue
Author: Song, Jun; Pan, Chuqiao; Li, Jinxiu; Bai, Ruisong; Zeng, Ziying; Han, Yunying; Chen, Zhao; Hou, Wei; Li, Yong; Ruan, Benfang Helen

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. 14, Issue 1, pp. 11-17. DOI: 10.1021/acsmedchemlett.2c00302
2、Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors
Author: Liu, Meiying; Zhou, Guizhen; Su, Wenhong; Gu, Yuejiao; Gao, Mingshan; Wang, Kun; Huo, Ruifeng; Li, Yupeng; Zhou, Zehui; Chen, Kaixian; Zheng, Mingyue; Zhang, Sulin; Xu, Tianfeng

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00490
3、Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors
Author: Liu, Meiying; Zhou, Guizhen; Su, Wenhong; Gu, Yuejiao; Gao, Mingshan; Wang, Kun; Huo, Ruifeng; Li, Yupeng; Zhou, Zehui; Chen, Kaixian; Zheng, Mingyue; Zhang, Sulin; Xu, Tianfeng

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. 183-190. DOI: 10.1021/acsmedchemlett.2c00490183
4、Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design
Author: Yu, Yang; Huang, Junhong; He, Hu; Han, Jing; Ye, Geyan; Xu, Tingyang; Sun, Xianqiang; Chen, Xiumei; Ren, Xiaoming; Li, Chunlai; Li, Huijuan; Huang, Wei; Liu, Yangyang; Wang, Xinjuan; Gao, Yongzhi; Cheng, Nianhe; Guo, Na; Chen, Xibo; Feng, Jianxia; Hua, Yuxia; Liu, Chong; Zhu, Guoyun; Xie, Zhi; Yao, Lili; Zhong, Wenge; Chen, Xinde; Liu, Wei; Li, Hailong

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00515
5、Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong In Vivo Anticancer Activity
Author: Hou, Wei; Chen, Zhao; Pan, Chuqiao; Ni, Maowei; Ruan, Haoqiang; Song, Jun; Lu, Shiying; Bhasin, Aman; Ruan, Benfang Helen

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00470
6、Development and Characterization of Fluorescent Probes for the G Protein-Coupled Receptor 35
Author: Wei, Lai; Xiang, Kaijing; Kang, Hongjian; Yu, Yancheng; Fan, Hongjie; Zhou, Han; Hou, Tao; Ge, Yonglin; Wang, Jixia; Guo, Zhimou; Chen, Yang; Zhao, Yaopeng; Liang, Xinmiao

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00461
7、Development of the Inverse Sonogashira Reaction for DEL Synthesis
Author: Luo, Ayun; Zhou, Hongxia; Hua, Qini; An, Yufang; Ma, Hangke; Zhao, Xue; Yang, Kexin; Hu, Yun Jin

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00477
8、Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist
Author: Dickson, Louise; Teall, Martin; Chevalier, Elodie; Cheung, Toni; Liwicki, Gemma M.; Mack, Stephen; Stephenson, Anne; White, Kathryn; Fosbeary, Richard; Harrison, David C.; Brice, Nicola L.; Doyle, Kevin; Ciccocioppo, Roberto; Wu, Chaobo; Almond, Sarah; Patel, Toshal R.; Mitchell, Philip; Barnes, Matt; Ayscough, Andrew P.; Dawson, Lee A.; Carlton, Mark; Burli, Roland W.

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00529